BioAgilytix (NC, USA), a Durham-based CRO, have announced the launch of customizable testing packages to address the requirements of employees and sponsors as a result of the COVID-19 pandemic.
Thermo Fisher Scientific (MA, USA), WuXi Diagnostics (Shanghai, China) and Mayo Clinic (MN, USA) are collaborating to develop and validate a serology test for COVID-19.
Emergency use authorization for Thermo Fisher Scientific’s COVID-19 diagnostic test expanded by US FDA
The US FDA has expanded the emergency use authorization granted to Thermo Fisher Scientific’s (MA, USA) COVID-19 diagnostic test. The expansion could facilitate workflow flexibility and increase test throughput.
Researchers have developed a tool that could help to monitor the spread of infectious diseases. The newly developed blood test could provide information about whether and when an individual has been exposed to infection.
A study led by researchers from Brussels Academic Hospital Lab (LHUB-ULB, Brussels, Belgium) indicates that the COVID-19 Ag Respi-Strip® – an antigen test for COVID-19 – could be a useful component in broader testing strategies.
Recently the United States Government announced a study to quantify undetected cases of COVID-19. We asked microsampling expert Hua Li (Boehringer Ingelheim Pharmaceuticals, CT, USA) for her perspectives on the potential benefits and applications of patient-centric microsampling amidst the coronavirus pandemic.
Medicines Discovery Catapult (Cheshire, UK), Retrogenix (High Peak, UK) and Peak Proteins (Cheshire, UK) have entered a new three-way collaboration to identify potential target receptors for COVID-19 therapies.
Researchers from Icahn School of Medicine at Mount Sinai (NY, USA) have developed a step-by-step protocol for a serological test that can detect antibodies to SARS-CoV-2.
Results of a new multi-institutional study led by researchers at University of Illinois at Urbana-Champaign (IL, USA) indicate that a portable testing device clipped to a smartphone could detect pathogens in biological samples in minutes.
Genedrive (Manchester, UK) and Cytiva (formerly GE Healthcare; IL, USA) have entered an international collaboration to develop a one step assay to detect SARS-CoV-2 for use on lab-based PCR instruments.